FRIDAY, MARCH 24, 2023
16:15-17:15
Chair
16:15
16:20
16:15
Roche faricimab DME Symposium: Advancing the management of DME via Ang-2/VEGF-A dual inhibition
João Figueira, Portugal
Welcome and opening remarks
João Figueira, Portugal
Evidence for Ang-2/VEGF-A inhibition in DME: Preclinical and Phase 3 data
Sara Vaz-Pereira, Portugal
Evidence for Ang-2/VEGF-A inhibition in DME: Preclinical and Phase 3 data
Sara Vaz-Pereira, Portugal
Chair:
João Figueira, Portugal
16:15
Welcome and opening remarks
João Figueira, Portugal
16:20
Evidence for Ang-2/VEGF-A inhibition in DME: Preclinical and Phase 3 data
Sara Vaz-Pereira, Portugal
16:35
Real world clinical case discussions
Sobha Sivaprasad, UK; David Almeida, USA
Audience Q&A with the panel
17:10
Closing remarks
João Figueira, Portugal
16:15-17:15
Roche faricimab DME Symposium: Advancing the management of DME via Ang-2/VEGF-A dual inhibition
